Feasibility and Prospective Study of a Dynamic Traction Device for Use During ESD
Launched by BAYLOR COLLEGE OF MEDICINE · Dec 19, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the TTS helix tack suture, which is designed to help during a procedure known as endoscopic submucosal dissection (ESD). ESD is a method used to remove abnormal growths in the digestive tract, such as tumors. The researchers at Baylor St. Luke's Medical Center want to see if using this device can make the procedure safer and less traumatic compared to other methods.
To participate in the trial, you need to be at least 18 years old and able to give your consent. Eligible patients are those who require ESD for certain types of growths in the colon or stomach, especially if previous attempts to remove them have failed or if the growths are larger than a certain size. The trial is not currently recruiting participants, but if you join, you can expect to undergo the ESD procedure using this new device, and your progress will be monitored. It's an exciting opportunity to be part of research that could improve treatment for gastrointestinal conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The patient is ≥ 18 years old.
- • 2. Patients can provide informed consent.
- 3. The patient is referred for ESD procedure of colonic or gastric neoplastic lesions and with one of the following criteria:
- • A- Lesions with prior failed resection of any size. B- Granular lateral spreading tumors (GLST) more than 30 mm. C- Non granular lateral spreading tumors (NGLST) more than 20 mm. D- Any lesion with suspected superficial submucosal invasion. E- Subepithelial lesions.
- Exclusion Criteria:
- • 1. The patient is \< 18 years old.
- • 2. The patient refuses and/or is unable to provide consent.
- • 3. The patient is a pregnant woman.
- • 4. Lesions with morphology: pedunculated type (Paris Ip, Ips).
- • 5. Appendiceal orifice or IC valve lesions
- • 6. Patients with lesions removed with other techniques besides ESD (submucosal tunneling technique \[STER\] or EMR).
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported